8k → ~720k peak sessions / mo.
A CDCES-reviewed diabetes publisher that went head-to-head with Healthline on hundreds of high-intent queries.
- Client
- Diabetic.org
- Market
- US · Nationwide
- Window
- 2020 → 2023 · Built and exited
- Organic sessions / mo (peak)
- ~720k
- CDCES / endocrinologist-reviewed articles
- 2,400+
- Ranked #1 vs Healthline / WebMD
- Dozens of terms
- Years operated
- ~3
Diabetic.org was an owned property. Chris built and operated it, then exited with the rest of the portfolio in 2023.
Diabetic.org is a consumer health property Chris built and ran personally, covering type-1, type-2, GLP-1s, insulin regimens, CGMs, and diabetic complications. Every clinical page was reviewed by a Certified Diabetes Care and Education Specialist (CDCES) or a board-certified endocrinologist. Three years of patient, peer-reviewed publishing built a content moat that ranked #1 against WebMD and Healthline on dozens of diabetes topics patients actually search. Part of a portfolio Chris exited in 2023.
The build started with the editorial bar, not the keyword list. Every page was written or reviewed by a named, credentialed clinician, used primary sources, and shipped with a disclosure the reader could actually click. Volume followed. It always does. The moat was the editorial paper trail Google (and every reader) could verify.
- 01
Clinical editorial bar
Wrote the editorial bar with a specialty lead before a single keyword was mapped. No shortcuts on what counts as a credible claim.
- 02
Topical authority map
Built a pillar / cluster topical model around the commercial search intents that actually drive pipeline for this vertical.
- 03
Named reviewer program
Specialty-matched reviewers on every clinical page. Linked-out professional profiles. Every sign-off archived for audit.
Rankings are the first receipt.
Trust is the asset.
Peer-reviewed medical content does two jobs. It ranks. Then, quietly, it does the harder one: it tells every reader, buyer, regulator, partner, and supplier that the brand is run by people who take healthcare seriously. Eyeballs are incidental. Credibility is the compounding asset.
- 01
CDCES community
Certified Diabetes Care and Education Specialists cited Diabetic.org inside patient-education handouts. A content asset stopped being content and became a tool the clinical community used.
- 02
Referral infrastructure
Endocrinology practices, CGM startups, and insulin-pump brands cited Diabetic.org in their own patient materials. The brand became infrastructure for other brands' credibility.
- 03
Category ownership
Out-ranking WebMD and Healthline wasn't the prize. The prize was that patients, clinicians, and brand managers came to think of Diabetic.org first when the specialty came up.
- 04
Acquirer diligence
Editorial depth, reviewer credentials, and audience composition were named transaction-value drivers when the property was acquired alongside the rest of the portfolio in 2023.
“Same playbook USARx ran, narrower niche. Real CDCES bylines, real peer review, years of patience. Volume shortcuts didn't beat it. Nobody's shortcut did.”
Give us a brief.
We'll send back a plan.
Tell us the brand, the reader, and the goal. Within three business days a credentialed clinician on our desk will hand-write a free editorial teardown and a 90-day roadmap. Yours to keep, even if you never hire us.
- · Written by a real MD / PharmD / RD, not a sales rep
- · 3 business days
- · No meeting required